From the National Eczema Association, Novato, CA.
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Dermatitis. 2021 Oct 1;32(1S):S62-S70. doi: 10.1097/DER.0000000000000715.
Atopic dermatitis (AD) is associated with considerable financial cost. However, the full burden of out-of-pocket (OOP) expenses is not well understood.
We sought to characterize the OOP health care expenses associated with AD management.
A 25-question voluntary online survey was administered to National Eczema Association members worldwide (n = 113,502). Inclusion criteria (US residents age ≥18 years who either self-reported had AD or were primary caregivers of individuals with AD) were met by 77.3% (1118/1447) of respondents.
Respondents reported OOP expenses in 3 categories: (1) health care providers and prescriptions, including health care provider visit deductibles (68.7% [686]), prescription co-pays (64.3% [635]), and prescriptions not covered by insurance (48.6% [468]); (2) nonprescription health care products, including moisturizers (94.3% [934]), hygiene products (85.0% [824], allergy medications (75.1% [715]), itch relievers (68.25% [647]), dietary supplements (52.2% [491]), and sleep aids (37.0% [336]); and (3) complementary approaches, including cleaning products (74.7% [732]), clothing/bedding (44.8% [430]), alternative medications (19.0% [180]), and adjunctive therapies (15.9% [150]). The median annual AD OOP expense was US $600 (range, US $0-$200,000), with 41.9% (364) reporting expenditures US $1000 or greater.
Out-of-pocket expenses place a significant financial burden on individuals with AD. Additional studies are needed to better understand associations and impact of OOP costs.
特应性皮炎（AD）与相当大的财务成本有关。然而，自付费用（OOP）的全部负担尚不清楚。
我们旨在描述与 AD 管理相关的 OOP 医疗费用。
向全球范围内的全国湿疹协会会员（n = 113502）进行了一项包含 25 个问题的自愿在线调查。符合条件的受访者为 1447 名美国居民，年龄≥18 岁，其中包括自我报告患有 AD 或为 AD 患者的主要护理人员（77.3% [1118/1447]）。
受访者报告了 3 类 OOP 费用：（1）医疗保健提供者和处方，包括医疗保健提供者就诊自付额（68.7% [686]）、处方共付额（64.3% [635]）和未保险的处方（48.6% [468]）；（2）非处方保健产品，包括保湿剂（94.3% [934]）、卫生产品（85.0% [824]）、过敏药物（75.1% [715]）、止痒剂（68.25% [647]）、膳食补充剂（52.2% [491]）和睡眠辅助剂（37.0% [336]）；（3）补充方法，包括清洁产品（74.7% [732]）、衣物/床上用品（44.8% [430]）、替代药物（19.0% [180]）和辅助疗法（15.9% [150]）。AD 的 OOP 年平均费用为 600 美元（范围为 0-200000 美元），41.9%（364 名）报告的支出为 1000 美元或更多。
自付费用给 AD 患者带来了重大的经济负担。需要进一步研究以更好地了解 OOP 成本的关联和影响。
